{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:44:44Z","timestamp":1777394684115,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jcjo.2020.12.016","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T03:55:00Z","timestamp":1611374100000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-0252","authenticated-orcid":false,"given":"Sameh E.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Laura","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishaal","family":"Bhambhwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Gallie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Krema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2020.12.016_bib0001","first-page":"197","article-title":"Genetics and molecular diagnostics in retinoblastoma\u2013an update","volume":"6","author":"Soliman","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0002","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0003","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jaapos.2009.09.004","article-title":"Management and outcome of unilateral retinoblastoma","volume":"13","author":"Mallipatna","year":"2009","journal-title":"J AAPOS"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0004","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ophtha.2019.04.003","article-title":"Clinical predictors at diagnosis of low-risk histopathology in unilateral advanced retinoblastoma","volume":"126","author":"Kletke","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/13816810.2016.1227458","article-title":"Psychosocial determinants for treatment decisions in familial retinoblastoma","volume":"38","author":"Soliman","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0006","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jfo.2015.03.003","article-title":"Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma","volume":"38","author":"Soliman","year":"2015","journal-title":"J Francais D Ophtalmologie"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0007","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jnci\/85.14.1121","article-title":"Mortality from second tumors among long-term survivors of retinoblastoma","volume":"85","author":"Eng","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.005","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity\u201d","author":"Munier","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0009","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3349\/ymj.2015.56.6.1478","article-title":"Treatment of retinoblastoma: the role of external beam radiotherapy","volume":"5","author":"Kim","year":"2015","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0010","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.ophtha.2006.04.032","article-title":"Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bjophthalmol-2019-313985","article-title":"Episcleral brachytherapy for retinoblastoma","volume":"104","author":"Echegaray","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2013.06.2045","article-title":"Salvage\/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma","volume":"87","author":"Francis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Murphree","year":"2005","journal-title":"Ophthalmol Clin North America"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3129\/i10-111","article-title":"Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma","volume":"46","author":"Krema","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0015","series-title":"Taylor and Hoyt's PaediatricOphthalmology and Strabismus","first-page":"424","article-title":"Retinoblastoma","author":"Gallie","year":"2017"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0016","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0017","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0161-6420(01)00797-7","article-title":"Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0018","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2007.11.004","article-title":"(106)Ruthenium brachytherapy for retinoblastoma","volume":"71","author":"Abouzeid","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0019","article-title":"Prior non-irradiative focal therapies do not compromise the efficacy of delayed episcleral plaque brachytherapy in retinoblastoma [e-pub ahead of print]","volume":"28","author":"Lucas","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pbc.20094","article-title":"Episcleral plaque brachytherapy for retinoblastoma","volume":"43","author":"Merchant","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0021","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ijrobp.2006.02.002","article-title":"Beta-ray brachytherapy with 106Ru plaques for retinoblastoma","volume":"65","author":"Schueler","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2011.11.002","article-title":"(1)(0)(6)Ruthenium plaque therapy (RPT) for retinoblastoma","volume":"84","author":"Murakami","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0023","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0024","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0025","doi-asserted-by":"crossref","first-page":"e34120","DOI":"10.1371\/journal.pone.0034120","article-title":"Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review","volume":"7","author":"Abramson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0026","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.12.016_bib0027","first-page":"2322","article-title":"DEPICT HEALTH supports clinical trial of sustained-release episcleral topotecan for retinoblastoma","volume":"60","author":"Gallie","year":"2019","journal-title":"Invest Ophtalmol Vis Sci"},{"issue":"suppl 2","key":"10.1016\/j.jcjo.2020.12.016_bib0028","first-page":"S1","article-title":"National Retinoblastoma Strategy Canadian Guidelines for Care \/ Strat\u00e9gie th\u00e9rapeutique du r\u00e9tinoblastome guide clinique canadien","volume":"44","year":"2009","journal-title":"Can J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:10:11Z","timestamp":1757794211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418221000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0008418221000016"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2020.12.016","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2020.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}